中华泌尿外科杂志
中華泌尿外科雜誌
중화비뇨외과잡지
CHINESE JOURNAL OF UROLOGY
2013年
11期
810-813
,共4页
宋宏程%黄澄如%孙宁%张潍平%何乐建%白继武%伏利兵
宋宏程%黃澄如%孫寧%張濰平%何樂建%白繼武%伏利兵
송굉정%황징여%손저%장유평%하악건%백계무%복리병
儿童%癌,肾细胞%血尿
兒童%癌,腎細胞%血尿
인동%암,신세포%혈뇨
Children%Carcinoma,renal cell%Hematuria
目的 总结小儿肾细胞癌的临床病理特点和远期疗效. 方法 回顾性分析1973年1月至2012年3月收治的29例儿童肾细胞癌患者的临床资料.患儿年龄2.5~ 16.0岁,平均9.6岁.男16例,女13例.左侧16例,右侧13例.无痛肉眼血尿17例(3例为外伤后血尿),血尿+腹部包块3例,腹部包块3例,腹痛2例,血尿+腹痛1例,B超检查偶然发现3例. 结果 29例中3例因肿瘤直径<7 cm行保留肾单位手术;1例因肿瘤直径15 cm包绕腹主动脉和下腔静脉行肿瘤姑息切除;1例肿瘤巨大,最大径25 cm,术中有肉眼残留;余24例均行根治性肾切除术.肿瘤直径2.5~25.0 cm,平均6.8 cm.T1N0M0 16例,T1N1M0 5例,T2N1M0 3例,T3N1M0 2例,T4N1M0 2例,T4N1M11例.病理检查示Xp11.2易位相关肾癌21例,其中淋巴结转移11例(52.4%),透明细胞癌6例,乳头状癌2例.21例获随访,其中Xp11.2易位相关肾癌13例、透明细胞癌6例、乳头状癌2例.随访时间1.5 ~ 34.0年,平均12.3年.3例(均为Xp11.2相关肾癌,T1N0M0 1例,T4N1M12例)肿瘤复发后死亡,18例(T1N0M011例,T1N1M02例,T2N1M03例,T3N1M01例和T4N1M11例)无瘤存活. 结论 儿童肾细胞癌少见,多见于5岁以上儿童,血尿为主要症状.Xp11.2易位相关肾癌为主要病理类型,易出现局部淋巴结转移,分期高,但在儿童表现为生物活性惰性.手术切除是主要的治疗方法,对于肿瘤直径<7 cm者主张行保留肾单位手术.对于Ⅰ、Ⅱ期和T1-2N1M0的局限性肾细胞癌可仅行手术切除,术后无需辅助治疗.
目的 總結小兒腎細胞癌的臨床病理特點和遠期療效. 方法 迴顧性分析1973年1月至2012年3月收治的29例兒童腎細胞癌患者的臨床資料.患兒年齡2.5~ 16.0歲,平均9.6歲.男16例,女13例.左側16例,右側13例.無痛肉眼血尿17例(3例為外傷後血尿),血尿+腹部包塊3例,腹部包塊3例,腹痛2例,血尿+腹痛1例,B超檢查偶然髮現3例. 結果 29例中3例因腫瘤直徑<7 cm行保留腎單位手術;1例因腫瘤直徑15 cm包繞腹主動脈和下腔靜脈行腫瘤姑息切除;1例腫瘤巨大,最大徑25 cm,術中有肉眼殘留;餘24例均行根治性腎切除術.腫瘤直徑2.5~25.0 cm,平均6.8 cm.T1N0M0 16例,T1N1M0 5例,T2N1M0 3例,T3N1M0 2例,T4N1M0 2例,T4N1M11例.病理檢查示Xp11.2易位相關腎癌21例,其中淋巴結轉移11例(52.4%),透明細胞癌6例,乳頭狀癌2例.21例穫隨訪,其中Xp11.2易位相關腎癌13例、透明細胞癌6例、乳頭狀癌2例.隨訪時間1.5 ~ 34.0年,平均12.3年.3例(均為Xp11.2相關腎癌,T1N0M0 1例,T4N1M12例)腫瘤複髮後死亡,18例(T1N0M011例,T1N1M02例,T2N1M03例,T3N1M01例和T4N1M11例)無瘤存活. 結論 兒童腎細胞癌少見,多見于5歲以上兒童,血尿為主要癥狀.Xp11.2易位相關腎癌為主要病理類型,易齣現跼部淋巴結轉移,分期高,但在兒童錶現為生物活性惰性.手術切除是主要的治療方法,對于腫瘤直徑<7 cm者主張行保留腎單位手術.對于Ⅰ、Ⅱ期和T1-2N1M0的跼限性腎細胞癌可僅行手術切除,術後無需輔助治療.
목적 총결소인신세포암적림상병리특점화원기료효. 방법 회고성분석1973년1월지2012년3월수치적29례인동신세포암환자적림상자료.환인년령2.5~ 16.0세,평균9.6세.남16례,녀13례.좌측16례,우측13례.무통육안혈뇨17례(3례위외상후혈뇨),혈뇨+복부포괴3례,복부포괴3례,복통2례,혈뇨+복통1례,B초검사우연발현3례. 결과 29례중3례인종류직경<7 cm행보류신단위수술;1례인종류직경15 cm포요복주동맥화하강정맥행종류고식절제;1례종류거대,최대경25 cm,술중유육안잔류;여24례균행근치성신절제술.종류직경2.5~25.0 cm,평균6.8 cm.T1N0M0 16례,T1N1M0 5례,T2N1M0 3례,T3N1M0 2례,T4N1M0 2례,T4N1M11례.병리검사시Xp11.2역위상관신암21례,기중림파결전이11례(52.4%),투명세포암6례,유두상암2례.21례획수방,기중Xp11.2역위상관신암13례、투명세포암6례、유두상암2례.수방시간1.5 ~ 34.0년,평균12.3년.3례(균위Xp11.2상관신암,T1N0M0 1례,T4N1M12례)종류복발후사망,18례(T1N0M011례,T1N1M02례,T2N1M03례,T3N1M01례화T4N1M11례)무류존활. 결론 인동신세포암소견,다견우5세이상인동,혈뇨위주요증상.Xp11.2역위상관신암위주요병리류형,역출현국부림파결전이,분기고,단재인동표현위생물활성타성.수술절제시주요적치료방법,대우종류직경<7 cm자주장행보류신단위수술.대우Ⅰ、Ⅱ기화T1-2N1M0적국한성신세포암가부행수술절제,술후무수보조치료.
Objective To discuss the unique biological,histological and clinical features of pediatric renal cell carcinoma (RCC).Methods A retrospective review and biological analysis of all RCC cases presenting to our hospital from January 1973 to March 2012 was undertaken.Results Twenty-nine RCC pediatric patients (16 boys,13 girls) with mean age of 9.6 (range 2.5-16.0) years were identified.The presentations included hematuria in 17 (58.6%) cases with 3 who developed hematuria after trauma,abdominal mass with hematuria in 3 (10.3%),abdominal mass in 3,abdominal pain in 2,abdominal pain with hematuria in 1,and incidentally finding in 3.The diameter of tumor was from 2.5 cm to 25.0 cm,mean 6.8 cm.According to TNM stage grouping system,16 cases were stage Ⅰ,10 stage Ⅲ,and 3 stage Ⅳ.Xp1 1.2 translocation RCC was identified in 21 patients,clear cell RCC 6,papillary RCC 2.Of the 29 cases,3 patients with the tumor less than 7-cm had nephron-sparing surgery.A 15-cm tumor was incompletely removed in 1 patient and another patient with a 25 cm× 18 cm×15 cm tumor had gross residual.Nephrectomy was performed for the affected kidney in the remaining 24 patients.Twenty-one patients (Xp1 1.2 translocation RCC 13 patients,clear cell RCC 6,papillary RCC only 2) were followed up from 1.5 to 34.0 years,18 were living well (T1N0M0 in 11 cases,T1N1M0 in 2,T2N1M0 in 3,T3N1M0 in 1 and T4N1M1 in 1) and 3 died of recurrence.Conclusions Although RCC is rare in children,pediatric RCC behaves in a distinct fashion compared with adult forms of RCC.Hematuria is the main symptom in pediatric RCC.Xp11.2 translocation RCC is the predominant form,associated with an advanced stage at diagnosis.Nephrectomy is the common treatment for RCC and nephron sparing surgery could be a reasonable option for patients with tumor smaller than 7 cm.For localized RCC (T1-2 N0-1 M0),simple kidney removal surgery is sufficient for treatment without lymph node dissection and postoperative adjuvant treatment.